User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey

The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
Thomas Römer, Doris Linsberger

Abstract

To identify the characteristics of an international population of women using the levonorgestrel-releasing intrauterine system (LNG-IUS) and their experiences with this contraceptive. Women who had used the LNG-IUS for six months or more completed a standardised questionnaire on reasons for use, user satisfaction and other aspects. A total of 8680 questionnaires were completed by survey participants in 18 countries across Europe and the Near East. The average woman using the LNG-IUS was 38 years old, was married or lived with her partner, and had two children. Overall, 95% of patients were satisfied with the LNG-IUS; the percentage rose to 99% among those using their second LNG-IUS. Reasons mentioned for using the LNG-IUS included the need for contraception (68%), its high efficacy (59%) and the shorter/lighter menstrual bleeding (55%). Of the women with prior bleeding problems, 93% reported an improvement in their symptoms with the LNG-IUS. Participants also rated the reliability, tolerability and convenience of the method highly. This survey provides insight into the profiles of LNG-IUS users. High levels of satisfaction with this method of contraception were reported by both first and second-time users. Our data suggest that...Continue Reading

References

Sep 29, 2004·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·S O Skouby
Jun 25, 2005·Current Opinion in Obstetrics & Gynecology·Paolo VercelliniEdgardo Somigliana
Aug 27, 2005·Obstetrical & Gynecological Survey·Jeffrey T Jensen
Mar 27, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A KriplaniN Agarwal
May 9, 2007·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·István Batár
May 29, 2007·Contraception·Sarah Prager, Philip D Darney
Dec 7, 2007·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists
Jan 28, 2009·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·David Cibula
Jul 1, 2009·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Sergio Haimovich

❮ Previous
Next ❯

Citations

Jul 9, 2013·Journal of Mid-life Health·Navneet MagonSuchitra N Pandit
Feb 4, 2014·Contraception·Matilda EkelundKristina Gemzell-Danielsson
May 19, 2011·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Annie J MiddletonNicola Singer
Aug 13, 2014·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Kai J BuhlingAlfred O Mueck
Feb 14, 2012·Sexual & Reproductive Healthcare : Official Journal of the Swedish Association of Midwives·Annelie Sköld, Margareta Larsson
Dec 19, 2015·Global Health, Science and Practice·David Hubacher
Aug 23, 2011·Acta Obstetricia Et Gynecologica Scandinavica·Kristina Gemzell-DanielssonOskari Heikinheimo
Jun 9, 2016·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Leticia G MoraesLuis Bahamondes
Apr 12, 2018·Expert Opinion on Pharmacotherapy·Giovanni GrandiFabio Facchinetti
May 3, 2013·Obstetrics and Gynecology·David HubacherKristina Gemzell-Danielsson
Aug 24, 2017·The Journal of Obstetrics and Gynaecology Research·Nelsilene M CarvalhoLuis Bahamondes
Jul 9, 2020·Journal of Clinical Medicine·Magdalena ZgliczynskaKatarzyna Kosinska-Kaczynska

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.